FDA not recognizing efficacy of psychopharmacologic therapiesNovember 2, 2021Alzheimer's & CognitionParkinson's Disease
Influenza tied to long-term increased risk for Parkinson’s diseaseNovember 2, 2021Parkinson's DiseaseMovement Disorders
Customized brain stimulation: New hope for severe depressionOctober 6, 2021Epilepsy & SeizuresParkinson's Disease
Worsening motor function tied to post COVID syndrome in Parkinson’s diseaseSeptember 30, 2021Parkinson's DiseaseCOVID-19 UpdatesMovement Disorders
Apple devices identify early Parkinson’s diseaseSeptember 27, 2021Parkinson's DiseaseMovement Disorders
Study identifies pandemic-related stressor in Parkinson’s diseaseSeptember 23, 2021Parkinson's DiseaseCOVID-19 UpdatesMovement Disorders
Efforts target underrepresented populations in Parkinson’s disease genetic studiesSeptember 23, 2021Parkinson's DiseaseMovement Disorders
Sublingual film well tolerated for Parkinson ‘off’ episodesSeptember 21, 2021Parkinson's DiseaseMovement Disorders
Survey identifies clinicians’ unease with genetic testingSeptember 21, 2021Parkinson's DiseaseGene TherapyMovement Disorders
Toward ‘superhuman cognition’: The future of brain-computer interfacesSeptember 3, 2021Parkinson's DiseaseMovement Disorders
Nonmotor symptoms common in Parkinson’sAugust 26, 2021Movement DisordersParkinson's DiseaseSleep MedicineAlzheimer's & Cognition
Anxiety, inactivity linked to cognitive impairment in Parkinson’sAugust 24, 2021Movement DisordersParkinson's Disease
Psychotic features among older adults tied to Parkinson’sAugust 23, 2021Movement DisordersParkinson's Disease
